Clofarabine Improves Relapse-Free Survival of Acute Myeloid Leukemia in Younger Adults with Micro-Complex Karyotype

Acute myeloid leukemia (AML) encompasses heterogeneous entities with dismal outcomes. Intermediate and unfavorable-risk AML represent the most difficult-to-treat entities. We recently reported the benefit of the clofarabine-based consolidation (CLARA) regimen compared to the standard high-dose cytar...

Descripción completa

Detalles Bibliográficos
Autores principales: Fenwarth, Laurène, Duployez, Nicolas, Thomas, Xavier, Boissel, Nicolas, Geffroy, Sandrine, Marceau-Renaut, Alice, Caillot, Denis, Raffoux, Emmanuel, Lemasle, Emilie, Marolleau, Jean-Pierre, Berthon, Céline, Cheok, Meyling H., Peyrouze, Pauline, Pigneux, Arnaud, Vey, Norbert, Celli-Lebras, Karine, Terré, Christine, Preudhomme, Claude, Dombret, Hervé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017244/
https://www.ncbi.nlm.nih.gov/pubmed/31905904
http://dx.doi.org/10.3390/cancers12010088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017244/
https://www.ncbi.nlm.nih.gov/pubmed/31905904
http://dx.doi.org/10.3390/cancers12010088

Ejemplares similares